Climb Bio (CLYM) Return on Capital Employed Growth (1y) (2022 - 2026)
Climb Bio (CLYM) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | -3,457.00 |
| 10 | Climb Bio | 968.54 Mn | 968.54 Mn | - | 1,202.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,202.00 |
| Dec 31, 2025 | -221.00 |
| Sep 30, 2025 | 192.00 |
| Jun 30, 2025 | 1,280.00 |
| Mar 31, 2025 | -3,198.00 |
| Dec 31, 2024 | -116.00 |
| Sep 30, 2024 | 552.00 |
| Jun 30, 2024 | -47.00 |
| Mar 31, 2024 | 2,629.00 |
| Dec 31, 2023 | -279.00 |
| Sep 30, 2023 | -681.00 |
| Jun 30, 2023 | -1,037.00 |
| Mar 31, 2023 | -1,880.00 |
| Dec 31, 2022 | -1,346.00 |
| Sep 30, 2022 | -449.00 |